Synthesis and morphine enhancement activity of N-[5-(2-phenoxyphenyl)-1,3, 4-oxadiazole-2-yl]-N′-phenylurea derivatives

Archiv der Pharmazie

Volumn 337, Issue 4, 2004, Pages 193-200

  Rad, Ali Almasi ^a   Sheikhha, Majid ^a   Hosseini, Rohollah ^a   Tabatabai, Sayyed Abbas ^b   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,3,4 Oxadiazole; Analgesia; CCK B antagonist; L 365,260; Morphine enhancement

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; MORPHINE; CHOLECYSTOKININ RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONFORMATION; CONTROLLED STUDY; ENERGY; EVALUATION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; SYNTHESIS;

ANALGESIA; ANIMALS; DRUG SYNERGISM; MALE; MICE; MOLECULAR CONFORMATION; MORPHINE; PHENYLUREA COMPOUNDS; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3042781961     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300822     Document Type: Article

References (18)

1. H. Ito, H. Sogabe, Y. Satoh, Drug Fut. 1995, 20, 587-599.
2. E. Lattmann, J. Sattayasai, D. C. Billington, D. R. Poyner, P. Puapairoj, S. Tiamkao, W. Airarat, H. Singh, M. Offel, J. Pharm. Pharmacol. 2002, 54, 827-834.
3. L. Revel, F. Makovec, Drug Fut. 1998, 23, 751-766.
4. M. G. Bock, R. M. Dipardo, B. E. Evans, K. E. Rittle, W. L. Whitter, V. M. Garsky, K. F. Gilbert, J. L. Leighton, K. L. Carson, E. C. McIlin, D. F. Veber, R. S. L. Chang, V. J. Lotti, S. B. Freedman, A. J. Smith, S. Patel, P. S. Anderson, R. M. Freidinger, J. Med. Chem. 1993, 36, 4276-4292.
5. M. B. VanNiel, S. B. Freedman, V. G. Matassa, S. Patel, R. R. Pengilley, A. J. Smith, Bioorg. Med. Chem. 1995, 5, 1421-1426.
6. O. Valverde, A. G. Blommaert, M. F. Zaluski, B. P. Roques, R. Maldonado, Eur. J. Pharmacol. 1995, 286, 79-93.
7. Z. Wiesenfeld-Hallin, G. A. Lucas, P. Alster, X-J. Xu, T. Hokfelt, Brain Research. 1999, 848, 78-89.
8. Z. Wiesenfeld-Hallin, X-J. Xu, Regulatory Peptides. 1996, 65, 23-28.
9. C. T. Dourish, M. F. O. Neill, J. Coughlan, S. J. Kitchener, D. Hawley, S. D. Iversen, Eur. J. Pharmacol, 1990, 176, 35-44.
10. T. Akbarzadeh, S. A. Tabatabai, M. J. Khoshnoud, B. Shafaghi, A. Shafiee, Bioorg. Med. Chem. 2003, 11, 769-773.
11. N. C. Yang, P. Kumler, S. S. Yang, J. Org. Chem. 1972, 37, 4022-4026.
12. F. L. Allen, P. Koch, H. Suschitzky, Tetrahedron. 1959, 6, 315-318.
13. A. Tambute, Fr. Demande 2348205. 1977 [Chem. Abstr. 1978, 89, P 24376r]
14. F. Firoozi, K. Javidnia, M. Kamali, A. Fooladi, A. Foroumadi, A. Shafiee, J. Heterocyclic Chem. 1995, 23, 123-127.
15. M. Mano, T. Seo, T. Matsuno, K. Imai, Chem. Pharm. Bull. 1976, 24, 2871-2876.
16. G. Puglisi, R. Pignatello, A. Panico, G. Mazzone, A. Corsaro, A. Caruso, M. G. Leone, M. A. Roxas, Eur. J. Med. Chem. 1989, 24, 277-286.
17. V. H. Gehlen, M. Justus, Justus Liebigs Ann. Chem. 1966, 692, 151-165.
18. Hyperchem; Hypercube, Inc. 1115 NW4th Street, Gainesweille, FL 32601, USA.